Success Metrics

Clinical Success Rate
90.0%

Based on 18 completed trials

Completion Rate
90%(18/20)
Active Trials
8(20%)
Results Posted
61%(11 trials)
Terminated
2(5%)

Phase Distribution

Ph phase_4
10
24%
Ph not_applicable
8
20%
Ph phase_3
6
15%
Ph phase_1
5
12%
Ph phase_2
9
22%

Phase Distribution

5

Early Stage

9

Mid Stage

16

Late Stage

Phase Distribution38 total trials
Phase 1Safety & dosage
5(13.2%)
Phase 2Efficacy & side effects
9(23.7%)
Phase 3Large-scale testing
6(15.8%)
Phase 4Post-market surveillance
10(26.3%)
N/ANon-phased studies
8(21.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

18 of 22 finished

Non-Completion Rate

18.2%

4 ended early

Currently Active

8

trials recruiting

Total Trials

41

all time

Status Distribution
Active(8)
Completed(18)
Terminated(4)
Other(11)

Detailed Status

Completed18
unknown11
Recruiting5
Active, not recruiting3
Terminated2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
41
Active
8
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (13.2%)
Phase 29 (23.7%)
Phase 36 (15.8%)
Phase 410 (26.3%)
N/A8 (21.1%)

Trials by Status

recruiting512%
terminated25%
unknown1127%
completed1844%
withdrawn25%
active_not_recruiting37%

Recent Activity

Clinical Trials (41)

Showing 20 of 41 trialsScroll for more
NCT05478551Phase 2

Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization

Active Not Recruiting
NCT07303582Phase 4

Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities

Recruiting
NCT00133861Phase 2

Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles

Completed
NCT05008731Phase 3

Cyclops Syndrome After Anterior Cruciate Ligament Reconstruction

Active Not Recruiting
NCT04829565Phase 4

Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb

Active Not Recruiting
NCT05403710

Botulinum Toxin Therapy in Hidradenitis Suppurativa

Recruiting
NCT05125029Phase 4

Botulinum Toxin in Raynaud's Phenomenon

Recruiting
NCT04630873Phase 1

Low or High Botox Dilution for the Hemiplegic Gait?

Recruiting
NCT06080438Phase 4

Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure

Terminated
NCT05990881Phase 3

Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

Recruiting
NCT06593821Not Applicable

Effect of Different Treatment Techniques on Masseter Muscle Thickness

Completed
NCT06583551Not Applicable

Effectiveness of Botox, Dry Needling, Pharmacological Treatment, and Manual Therapy for Bruxism-Induced Myalgia

Completed
NCT06386848

Strategy to Adapt Botulinum Toxin Doses in Dystonia

Unknown
NCT04432285

Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia

Unknown
NCT04249687Phase 3

Treatment of Moderate to Severe Lateral Canthal Lines

Completed
NCT04249583Phase 3

Treatment of Moderate to Severe Glabellar Lines

Completed
NCT02139319Phase 1

Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee

Completed
NCT01780636Phase 2

Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome

Terminated
NCT03484754Not Applicable

Infiltrations of OnaBotulinum Toxin A in Resistant Depression: Comparison of Two Facial Injection Sites.

Unknown
NCT02623829Phase 2

Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
41